USFDA issues no observations to Ajanta Pharma's Dahej plant

10 Apr 2017 Evaluate

Ajanta Pharma’s formulation facility at Dahej was inspected by US Food and Drug Administration (USFDA) from April 3 to April 7, 2017. At the end of the inspection, no Form 483 was issued to the company.

Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.

Ajanta Pharma Share Price

2414.55 31.95 (1.34%)
14-May-2024 14:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1544.40
Dr. Reddys Lab 5905.90
Cipla 1370.50
Zydus Lifesciences 981.65
Lupin 1640.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.